CARMIEL, Israel, June 30, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein...
Read More Details
Finally We wish PressBee provided you with enough information of ( Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes® )
Also on site :
- Occupation conducts military exercise on border with Jordan after completion of "Gilead" Division
- Numbrix 9 - June 30
- 21-year-old Baloch student becomes another victim of extrajudicial killing by Pakistani forces